Synapse

← BMJ

Papers in BMJ

Page 14 · newest first

  1. AI in the doctor-patient encounterBMJ · 2025
  2. Agreement of treatment effects in decentralised trials versus traditional trials: meta-epidemiological studyBMJ · 2025
  3. Advances in the management of gastric cancerBMJ · 2025
  4. “Forever chemicals”: What are they and what are the health risks?BMJ · 2025
  5. Redressing inequities in women’s cardiovascular healthBMJ · 2025
  6. How e-cigarettes compromise children’s human rightsBMJ · 2025
  7. EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trialBMJ · 2025
  8. Duration of anticoagulation for unprovoked venous thromboembolismBMJ · 2025
  9. Continued versus discontinued oral anticoagulant treatment for unprovoked venous thromboembolism: target trial emulationBMJ · 2025
  10. Flu in numbers: NHS faces one of worst winters ever, officials warn, amid concern over mutated strainBMJ · 2025
  11. Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreementsBMJ · 2025
  12. Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricingBMJ · 2025
  13. Pharmaceutical governance system for costly drugs through human rights due diligenceBMJ · 2025
  14. Equitable access to costly new drugsBMJ · 2025
  15. Policies to promote affordability and access across the life cycle of costly new drugsBMJ · 2025
  16. Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trialBMJ · 2025
  17. Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreementsBMJ · 2025
  18. Policies to promote affordability and access across the life cycle of costly new drugsBMJ · 2025
  19. Equitable access to costly new drugsBMJ · 2025
  20. Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricingBMJ · 2025
  21. Pharmaceutical governance system for costly drugs through human rights due diligenceBMJ · 2025
  22. Global patterns of youth alcohol consumption and attributable harmBMJ · 2025
  23. Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviewsBMJ · 2025
  24. Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviewsBMJ · 2025
  25. Torture and health worker complicity in Israeli detention sitesBMJ · 2025
  26. New sociopolitical governance models are needed to tackle health challenges in the AmazonBMJ · 2025
  27. Health systems in the Amazon need to be reimagined for a more sustainable futureBMJ · 2025
  28. Brazil and the climate emergency: why the medical curriculum must include climate educationBMJ · 2025
  29. The Amazon is one of Earth’s major climate stabilisers—we must protect the rainforest and its biodiversityBMJ · 2025
  30. Advances in the management of acute decompensated heart failureBMJ · 2025
  31. Greenness and hospital admissions for cause specific mental disorders: multicountry time series studyBMJ · 2025
  32. Provider billing margin and cancer treatment selection: population based cohort studyBMJ · 2025
  33. Cause specific mortality risks associated with tropical cyclones in multiple countries and territories: two stage, time series studyBMJ · 2025
  34. Tackling the complex links between climate change, conflict, and healthBMJ · 2025
  35. Responding to rising heat in workplaces and homes of low income workersBMJ · 2025
  36. Climate change is driving a surge of infectious diseases in BrazilBMJ · 2025
  37. The impact of noise pollution on healthBMJ · 2025
  38. From rainforest communities to inner city patients—the Brazilian doctors working to combat the climate crisisBMJ · 2025
  39. Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)BMJ · 2025
  40. Medicine’s reckoning with genocide and crimes against humanityBMJ · 2025
  41. From dumplings to diagnoses: how China’s delivery drivers became healthcare heroesBMJ · 2025
  42. Exercise for people living with knee osteoarthritisBMJ · 2025
  43. Effects of extreme heat on physiology, morbidity, and mortality under climate change: mechanisms and clinical implicationsBMJ · 2025
  44. Risk of infection and wound dehiscence after use of prophylactic antibiotics in episiotomy or second degree tear (REPAIR study): single centre, double blind, placebo controlled randomised trialBMJ · 2025
  45. Changes to UK soft drinks tax are a missed opportunity for public healthBMJ · 2025
  46. Covariate adjustment in cluster randomised trials: a practical guideBMJ · 2025
  47. Futureproofing medicine: why geriatric medicine student societies are a mustBMJ · 2025
  48. Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trialBMJ · 2025
  49. How attacking healthcare has become a strategy of warBMJ · 2025
  50. International collaboration in cohort studies in China: opportunities and challengesBMJ · 2025